Cancer Letters
Volume 286, Issue 1 , Pages 29-37, 1 December 2009

The aflatoxin-induced TP53 mutation at codon 249 (R249S): Biomarker of exposure, early detection and target for therapy

International Agency for Research on Cancer, 150 Cours Albert Thomas, 69372 Lyon Cedex 08, France

Received 4 November 2008; received in revised form 26 February 2009; accepted 27 February 2009. published online 20 April 2009.

Abstract 

Hepatocellular Carcinoma (HCC) in high-incidence areas (sub-Saharan Africa, South-Eastern Asia) often contains a somatic mutation at codon 249 in TP53 (R249S). This mutation is rare in low-incidence areas of Europe and the United States. There is evidence that R249S occurs as the result of mutagenesis by aflatoxin in a context of HBV chronic infection. Here, we summarize the mechanisms of R249S formation and the possible role of p.R249S protein in HCC pathogenesis. Next, we discuss the significance of R249S as a biomarker to study the natural history of HCC and as a target for therapeutic approaches aimed at restoring wild-type p53 activity.

Keywords: Aflatoxin, Hepatitis B virus, Codon 249, p.R249S, Biomarker, PRIMA-1

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0304-3835(09)00169-4

doi:10.1016/j.canlet.2009.02.057

Cancer Letters
Volume 286, Issue 1 , Pages 29-37, 1 December 2009

Article Tools

* Image Usage & Resolution